Dr Mehdi Touat
- Specialty
- Neuro-oncologist, expert in primary brain tumors in adults
- Hospital
- Hôpital Pitié Salpétrière (Paris), APHP, Sorbonne Université, Institut du Cerveau
- Latest articles
-
- Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study. (Apr 1, 2026)
- 18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors. (Feb 2, 2026)
- RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma. (Jan 8, 2026)
- Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion. (Dec 27, 2025)
- Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases. (Aug 4, 2025)